.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cipla
Dow
Merck
Queensland Health
US Army
Argus Health
Harvard Business School
US Department of Justice
Julphar
Chinese Patent Office

Generated: July 22, 2017

DrugPatentWatch Database Preview

Braintree Labs Company Profile

« Back to Dashboard

What is the competitive landscape for BRAINTREE LABS, and when can generic versions of BRAINTREE LABS drugs launch?

BRAINTREE LABS has two approved drugs.

There is one US patent protecting BRAINTREE LABS drugs.

There are eighteen patent family members on BRAINTREE LABS drugs in thirteen countries.

Summary for Applicant: Braintree Labs

Patents:1
Tradenames:2
Ingredients:2
NDAs:2
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Braintree Labs
SUCLEAR
magnesium sulfate; polyethylene glycol 3350; potassium chloride; potassium sulfate; sodium bicarbonate; sodium chloride; sodium sulfate
SOLUTION;ORAL203595-001Jan 18, 2013DISCNYesNo► Subscribe► Subscribe
Braintree Labs
SUPREP BOWEL PREP KIT
magnesium sulfate; potassium sulfate; sodium sulfate
SOLUTION;ORAL022372-001Aug 5, 2010AARXYesYes6,946,149► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for BRAINTREE LABS drugs

Drugname Dosage Strength Tradename Submissiondate
sodium sulfate, potassium sulfate and magnesium sulfate
Oral Solution17.5 g/3.13 g/1.6 g per bottle
SUPREP BOWEL PREP KIT
11/8/2010

International Patent Family for Braintree Labs Drugs

Country Document Number Estimated Expiration
Hong Kong1148935► Subscribe
Canada2484303► Subscribe
Cyprus1110011► Subscribe
Denmark1499331► Subscribe
Austria528011► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Braintree Labs Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
90006-4Sweden► SubscribePRODUCT NAME: ACETYLSALICYLSYRA OCH ESOMEPRAZOLMAGNESIUMTRIHYDRAT; NAT. REG. NO/DATE: MTNR 44371 20110930; FIRST REG.: PT 5402359MFL 20110812
00615Netherlands► SubscribePRODUCT NAME: NATRIUMSULFAAT, MAGNESIUMSULFAAT EN KALIUMSULFAAT; NAT. REGISTRATION NO/DATE: RVG 110863 20130417; FIRST REGISTRATION: BE 434323 20130220
C/GB01/006United Kingdom► SubscribePRODUCT NAME: ESOMEPRAZOLE AS MAGNESIUM TRIHYDRATE; REGISTERED: SE 15945 20000310; SE 15946 20000310; UK PL 17901/0068-0069 20000727
0483Netherlands► SubscribePRODUCT NAME: NAXOPREN EN ESOMEPRAZOL ALS MAGNESIUMTRIHYDRAAT; NATIONAL REGISTRATION NO/DATE: RVG 106235 20101118; FIRST REGISTRATION: GB PL 17091/0263 - 0001 20101105
0130010 00080Estonia► SubscribePRODUCT NAME: NAATRIUMSULFAAT, MAGNEESIUMSULFAATHEPTAHUEDRAAT JA;REG NO/DATE: RR-4/5 04.03.2013
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Fuji
Baxter
Federal Trade Commission
Boehringer Ingelheim
Covington
Dow
Farmers Insurance
Medtronic
McKesson
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot